GELS (Gelteq) Common Stock: $23.98 Mil (As of Dec. 2025)


GELS Gelteq Ltd GELS
8 GF Score
Price $0.60
! 3 Warning Signs
View Full Analysis

What is Gelteq Common Stock?

Gelteq GELS -8.78% 8 Common Stock is $23.98 Mil as of Dec. 2025. GuruFocus rates GELS with a GF Score™ of 8/100. The stock has 3 warning signs investors should review.

Gelteq's quarterly common stock increased from Dec. 2024 ($21.28 Mil) to Jun. 2025 ($22.10 Mil) and increased from Jun. 2025 ($22.10 Mil) to Dec. 2025 ($23.98 Mil).

Gelteq's annual common stock declined from Jun. 2023 ($17.86 Mil) to Jun. 2024 ($17.67 Mil) but then increased from Jun. 2024 ($17.67 Mil) to Jun. 2025 ($22.10 Mil).

Gelteq Common Stock Historical Data

* Premium members only.

The historical data trend for Gelteq's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq Common Stock Chart

Gelteq Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 19.06 17.78 17.86 17.67 22.10

Gelteq Semi-Annual Data
Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only 0.00 17.67 21.28 22.10 23.98
GELS
8GF Score
Gelteq Ltd GELS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gelteq Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $23.98 Mil mean?
Gelteq (GELS) has a Common Stock of $23.98 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gelteq and its competitors.
Is Gelteq's Common Stock too high?
Gelteq's current Common Stock is $23.98 Mil. Overall, Gelteq has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's Common Stock compare to YCBD and AKAN?
Gelteq's Common Stock of $23.98 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gelteq and its competitors. Gelteq's current Common Stock is $23.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current Common Stock of $23.98 Mil. The current Common Stock is $23.98 Mil. Gelteq's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Gelteq (GELS), the current Common Stock is $23.98 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelteq Business Description

Address 644 Chapel Street, Level 19, South Yarra, VIC, AUS, 3141
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
8GF Score

Get the complete analysis for GELS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price